These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1176196)

  • 21. T and B lymphocytes in malignant melanoma patients.
    Babusiková O; Novotná L; Schneková K; Turková D; Havránková M
    Neoplasma; 1976; 23(6):635-44. PubMed ID: 1087378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The differential reactivity of benign and malignant nevomelanocytic lesions with mouse monoclonal antibody TNKH1.
    Nakanishi T; Hashimoto K
    Cancer; 1987 Apr; 59(7):1340-4. PubMed ID: 3545436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
    Bodey B; Bodey B; Siegel SE; Luck JV; Kaiser HE
    Anticancer Res; 1996; 16(6B):3439-46. PubMed ID: 9042204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ultrastructure of benign pigmented naevi and melanocarcinomas in man.
    Curran RC; McCann BG
    J Pathol; 1976 Jul; 119(3):135-46. PubMed ID: 956954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative ultrastructural features of maturing mononuclear phagocytes in rat peritoneal fluids.
    Mayhew TM
    Experientia; 1979 Mar; 35(3):390-2. PubMed ID: 446631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electron microscopy findings in malignant melanoma of nose.
    Wright JL; Heenan PJ
    ORL J Otorhinolaryngol Relat Spec; 1975; 37(4):233-6. PubMed ID: 1237844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
    Moretti S; Spallanzani A; Pinzi C; Prignano F; Fabbri P
    J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
    Speeckaert R; van Geel N; Vermaelen KV; Lambert J; Van Gele M; Speeckaert MM; Brochez L
    Pigment Cell Melanoma Res; 2011 Apr; 24(2):334-44. PubMed ID: 21029398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects.
    Sulit HL; Golub SH; Irie RF; Gupta RK; Grooms GA; Morton DL
    Int J Cancer; 1976 Apr; 17(4):461-8. PubMed ID: 945229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of uveal melanocyte destruction in melanoma-bearing swine with large granular lymphocyte cells.
    Richerson JT; Burns RP; Misfeldt ML
    Invest Ophthalmol Vis Sci; 1989 Dec; 30(12):2455-60. PubMed ID: 2592158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 51Cr release and microcytotoxicity assays against human melanoma cells.
    Hersey P; Edwards J; Edwards A; Adams E; Kearney R; Milton GW
    Int J Cancer; 1975 Jul; 16(1):164-72. PubMed ID: 1080748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrastructure of spontaneously differentiated human malignant melanocytes cultured from primary tumors.
    Aubert C; Chirieceanu E; Foa C; Delain E
    J Natl Cancer Inst; 1977 Jan; 58(1):29-35. PubMed ID: 833862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,
    de Vries JE; Cornain S; Rumke P
    Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
    O'Neill PA; Mackler BF; Romsdahl MM
    J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B core and surface antigens in liver tissue. Light and electron microscopic localization by the peroxidase-labeled antibody method.
    Yamada G; Nakane PK
    Lab Invest; 1977 Jun; 36(6):649-59. PubMed ID: 325296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens: production, partial characterization and immunohistochemical analysis].
    Fukaya T
    Hokkaido Igaku Zasshi; 1991 May; 66(3):300-10. PubMed ID: 1885156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes.
    Maeda K; Jimbow K
    Cancer; 1987 Feb; 59(3):415-23. PubMed ID: 3539311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in peroxidase localization of rabbit peritoneal macrophages after surface adherence.
    Bodel PT; Nichols BA; Bainton DF
    Am J Pathol; 1978 Apr; 91(1):107-17. PubMed ID: 645814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
    Garbelli S; Mantovani S; Palermo B; Giachino C
    Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation.
    Houghton AN; Albino AP; Cordon-Cardo C; Davis LJ; Eisinger M
    J Exp Med; 1988 Jan; 167(1):197-212. PubMed ID: 2891780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.